United States · 
What does L Capital Partners invest in?
L Capital Partners invests most often at Series B and Series C (50% of the rounds on record), in sectors such as Biotechnology.
L Capital Partners highlights
- 01
17 rounds on record
- 02
Mostly Series B and Series C: 50% of its rounds
- 03
Sole investor in 1 rounds, median $4.0M
- 04
2 exits from the portfolio
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- Biotechnology
- Based in
- United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first17 appearances
- 2012
2 rounds
- Apr
- Feb
- 2010
1 round
- Aug
- 2009
2 rounds
- May
- Apr
- 2008
4 rounds
- Nov
- Nov
- Jun
- Mar
- 2007
4 rounds
- Dec
- Oct
- Apr
- Feb
- 2006
2 rounds
- Sept
- Jun
- 2005
2 rounds
- Aug
- Aug
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration24 named
AFAllan Fernandez FajardoEXECUTIVE DIRECTOR AND SECRETARYiFiling they signed
AAAmy A. KnoxVICE PRESIDENTiFiling they signed
AAAmy A. YeungEXECUTIVE DIRECTORiFiling they signed
AAAndrea A. PassarellaASSISTANT VICE PRESIDENTiFiling they signed
AJAndrew J. HayesEXECUTIVE DIRECTORiFiling they signed
AJAndrew Jason MurrayEXECUTIVE DIRECTORiFiling they signed
CACaren A. HolzhauerASSISTANT VICE PRESIDENTiFiling they signed
CACarla A. HarrisMANAGING DIRECTORiFiling they signed
CJCatherine J. HongEXECUTIVE DIRECTORiFiling they signed
CAChristopher A. MorserMANAGING DIRECTORiFiling they signed
DADavid A. FleckensteinVICE PRESIDENTiFiling they signed
DADavid A. WiltonMANAGING DIRECTORiFiling they signed
DJDavid J. BoyleMANAGING DIRECTORiFiling they signed
DEDima Elizabeth SkvortsovEXECUTIVE DIRECTORiFiling they signed
DADwayne A. CoitVICE PRESIDENTiFiling they signed
EJEban J. CucinottaMANAGING DIRECTORiFiling they signed
EMEdmond MoriartyCHAIRMAN AND MANAGING DIRECTORiFiling they signed
EJEdward J. GoldsteinEXECUTIVE DIRECTORiFiling they signed
EAEric A. StampfelMANAGING DIRECTORiFiling they signed
FEFrancie Elizabeth TaiEXECUTIVE DIRECTORiFiling they signed
GAGeoff A. KronVICE PRESIDENTiFiling they signed
GAGina A. PanchellaASSISTANT VICE PRESIDENTiFiling they signed
JAJames A. SperansMANAGING DIRECTORiFiling they signed
JEJanet Elizabeth PaikEXECUTIVE DIRECTOR AND TREASURERiFiling they signed
We also hold 51 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
TengionListedUndisclosedApr 2010
Protez PharmaceuticalsBought by Novartis$400MJun 2008
An exit counts when it came after the firm's first round in the company. From historical deal records.